Skip to content
New platform coming soon — AI-Based Analysis with Human-Generated Insights
Stock Target Advisor Stock Target Advisor Market intelligence
  • Research ▾
    • Equity Reports
    • STA Portfolio
    • Top Stocks
  • Market Analysis
  • Analyst Ratings
  • Stock Research Tools ▾
    • Analyst Target Tool
    • Analyst Ranking Tool
    • Stock Analysis Tool
  • About ▾
    • About STA
    • Services
    • Contribute
    • Contact
  • Social Media ▾
    • YouTube
    • Blossom
    • Substack
    • TikTok

Browse research

Tag: Earnings

SoFi Technologies Reports 20% Revenue Surge and $17M Net Income for Q2 2024
Market News & Insights Jul 30, 2024

SoFi Technologies Reports 20% Revenue Surge and $17M Net Income for Q2 2024

SoFi Technologies (SOFI) has reported its financial results for Q2 2024 today. The company achieved significant milestones, including a net revenue of…

#banking #Earnings
SBA Communications Q2 2024 Earnings: Key Highlights and Investor Implications
Market News & Insights Jul 30, 2024

SBA Communications Q2 2024 Earnings: Key Highlights and Investor Implications

SBA Communications Corp (SBAC) has recently released its Q2 2024 earnings report, providing investors with crucial insights into the company’s performance and…

#Dividends #Earnings #interest rates
Canadian Analyst Updates
Market News & Insights Jul 30, 2024

TMX Group Limited: Stock Forecast & Analysis

TMX Group (X:CA) On Monday July 29th, National Bank Financial (Analyst Rank#21) issued a research report, updating the research firm’s coverage on…

#analyst ratings #banking #Canadian Markets
Lithium Americas: Stock Forecast & Fundamental Analysis
Market News & Insights Jul 30, 2024

Lithium Americas: Stock Forecast & Fundamental Analysis

Lithium Americas (LAC:CA) Piper Jaffray (Analyst Rank#14) recently issued a research report reiterating the firm’s “Neutral” rating for Lithium Americas Corp, setting…

#analyst ratings #Canadian Markets #Earnings
Iovance Biotherapeutics Inc: Piper Jaffray Downgrades on Product Development Concerns
Market News & Insights Jul 30, 2024

Iovance Biotherapeutics: Piper Jaffray Downgrades on Product Development Concerns

Iovance Biotherapeutics (IOVA) Date: July 29, 2024 Piper Jaffray (Analyst Rank#14) recently downgraded Iovance Biotherapeutics Inc (IOVA) from a “Buy” rating to…

#analyst ratings #Dividends #Earnings

Posts pagination

Previous 1 … 446 447 448 449 450 … 671 Next
Stock Target Advisor

Timely market news, analyst rating changes, and practical investment research for investors around the world.

  • Research
  • Analyst Ratings
  • Market Analysis
  • Top Stocks
  • About Us
  • Contact Us
  • Contribute a Post
© 2026 Stock Target Advisor. All rights reserved.

STA RESEARCH

Get the STA Research Professional Newsletter

Market outlook, portfolio updates, technical analysis and stock ideas—US$5/month.

See What’s Included →

Monthly subscription. Secure checkout with PayPal.